HOME > TOP STORIES

TOP STORIES

REGULATORY 41,254 ADR Reports Received from Marketing Authorization Holders in FY2012: MHLW

August 13, 2013
BUSINESS Payments to Healthcare Professionals by 10 Drug Makers Top 150 Billion Yen

August 13, 2013
REGULATORY MHLW Diovan Committee: 3 More Universities Give 1st Probe Updates, SMART Data Rapped “Sloppy”

August 12, 2013
BUSINESS AZ’s Exenatide Promotion to Break Free from Weight-Loss Image of GLP-1 Receptor Agonists

August 9, 2013
REGULATORY MHLW Taps 12 Experts to Serve on Diovan Study Committee; J-CLEAR’s Kuwajima, JAMS’s Sone on the List

August 9, 2013
REGULATORY PMDA to Make Public Adverse Reactions Reported by Patients by Year-End

August 8, 2013
ACADEMIA NCC Sets Sights on World’s Top Development Hub with New Exploratory Clinical Research Center

August 7, 2013
ORGANIZATION Kenporen Report Recommends Reference to Measures Taken in UK, France to Further Promote Use of Generics in Japan

August 7, 2013
ACADEMIA Draft of Hypertension Guidelines Recommends CCBs, ARBs, ACE Inhibitors, and Diuretics as First-Line Drugs, Excludes Beta Blockers

August 6, 2013
REGULATORY EAD Director to Personally Visit Hospitals to Urge Early Price Agreement

August 5, 2013
BUSINESS Apo Plus to Hire 1,000 Contract MRs by 2013-End

August 2, 2013
REGULATORY Distribution Reform and Perpetuation of Premium for New Drug Development Are Immediate Top-Priority Issues: EAD Director Jo

August 2, 2013
REGULATORY CSIMC Subcommittee Discusses Revisions of Drug Pricing Rules; Some Reps Oppose Proposed Rewards for Innovation

August 1, 2013
ACADEMIA Ex-Novartis Employee Manipulated Blood Pressure Data in JIKEI Study: Univ. Probe

July 31, 2013
BUSINESS Novartis’s Third-Party Probe Finds “No Evidence” Indicating Data Falsification by Ex-Employee; Truth behind Diovan Woe Not Yet Uncovered

July 30, 2013
REGULATORY PAFSC’s Second Committee Recommends Approval for Bronchial Asthma Treatment Flutiform, Others

July 29, 2013
ORGANIZATION Red Cross Hospitals to Share Information on Drug Discount Rates

July 29, 2013
REGULATORY MHLW-MEXT Joint Committee Agrees to Require Researchers to Store Clinical Research Data for Long Periods

July 26, 2013
BUSINESS OncoTherapy, Panasonic Healthcare to Codevelop Immune Monitoring System to Evaluate Effects of Cancer Vaccines

July 26, 2013
REGULATORY MHLW Might Submit Bill on Online OTC Sales to Extraordinary Diet Session: PFSB Head

July 25, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…

COLUMN

More Positions, More Candidates: A Snapshot of Movement in Japan’s Pharma Industry

By Philip Carrigan

Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…